Breaking News: Shaping the future of AMD and DME

Theme:
Co-Developed Symposium
What:
Co-Developed Symposium | Symposium élaboré conjointement
When:
6:30 AM, Sunday 12 Jun 2022 (1 hour 30 minutes)
Breaks:
Continental Breakfast    07:00 AM to 08:00 AM (1 hour)
Where:
Halifax Convention Centre - C3
How:

LEARNING OBJECTIVES

At the end of this symposium, participants will be able to:

  • Identify the critical unmet needs in neovascular AMD and DME management
  • Demonstrate a comprehensive understanding of new therapeutic agents and their mechanism of action in nAMD and DME management
  • Examine how to incorporate new therapeutic options into current management strategies for patients with nAMD and DME
  • Apply new insights from multi-modal imaging platforms to optimize diagnosis and management in the retina clinic

CanMEDS Roles: Medical Expert, Scholar

SCIENTIFIC PLANNING COMMITTEE
Varun Chaudhary, MD, Chair
Arif Samad, MD
Sarah Mullen, MD
 

This symposium was co-developed with the Canadian Ophthalmological Society and Roche, in order to achieve scientific integrity, objectivity and balance.

Varun Chaudhary
Varun Chaudhary
Moderator
Scientific Planning Committee Chair - Co-Developed Symposium
Michael Ip
Michael Ip
Keynote speaker
Keynote Speaker
Sunir J. Garg, MD, FACS, FASRS
Sunir J. Garg, MD, FACS, FASRS
Speaker
Retina
Dr. Wai-Ching Lam
Dr. Wai-Ching Lam
Speaker
Scientific Planning Committee - Co-Developed Symposium

Sub Sessions

Session detail
Allows attendees to send short textual feedback to the organizer for a session. This is only sent to the organizer and not the speakers.
To respect data privacy rules, this option only displays profiles of attendees who have chosen to share their profile information publicly.

Changes here will affect all session detail pages